Innovative Technology Use Ukko leverages cutting-edge technologies such as artificial intelligence, computational biology, and plant science, making it an ideal partner for companies seeking advanced biotech solutions and digital transformation in health-focused research.
Strategic Funding and Growth With a recent $40 million Series B funding led by Bayer and annual revenues between $10 million and $25 million, Ukko presents opportunities for strategic investment, partnership, and joint development projects in food allergy therapies.
Expanding Market Reach Having offices in Tel Aviv and Palo Alto positions Ukko to tap into both innovative Israeli biotech ecosystems and the thriving Silicon Valley tech landscape, offering potential collaborations in AI-driven biotech innovations.
Targeted Industry Focus Ukko's specialization in developing healthier food options and therapies for food allergies aligns with growing consumer demand for allergen-free and health-conscious products, creating sales opportunities with food producers, healthcare providers, and wellness brands.
Competitive Positioning Operating alongside large biotech firms with extensive revenue and workforce, Ukko's focus on immunology and computational biology positions it as a specialized innovator, ideal for partnerships that require niche biotech expertise and advanced R&D capabilities.
$1B$10B
$1M$10M
$1B$10B
$10B
$10B
$1B$10B
$1B$10B
$1B$10BUkko uses 8 technology products and services including Google Analytics Enhanced eCommerce, Fastly, WordPress, and more. Explore Ukko's tech stack below.
| Ukko Email Formats | Percentage |
| First@ukko.us | 50% |
| First@ukko.us | 50% |
Biotechnology ResearchTel Aviv, Israel51-200 Employees
Ukko is improving the lives of millions that suffer from food allergies and disorders. We are using cutting edge technologies in immunology, computational biology, and plant science to develop a new approach. We have offices in Tel Aviv, Israel and Palo Alto, California.
Company Overview
Funding & FinancialsUkko has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Jan 27, 2021 in the amount of $40M.
Ukko's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsUkko has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Jan 27, 2021 in the amount of $40M.
Ukko's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com